Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2010

Jan 22, 2010

34301_dirs_2010-01-22_c34b3c81-68d0-4379-a396-a4e775033944.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-01-21

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-01-21 Common Stock M 5625 $4.4 Acquired 130425 Indirect
2010-01-21 Common Stock M 4375 $3.12 Acquired 134800 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-01-21 Non-Qualified Stock Option (right to buy) $4.4 M 5625 Disposed 2013-01-28 Common Stock (5625) Direct
2010-01-21 Non-Qualified Stock Option (right to buy) $3.12 M 4375 Disposed 2015-02-02 Common Stock (4375) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 20911 Indirect
Common Stock 34909 Indirect

Footnotes

F1: These securities are owned by David Rickey, TTEE FBO the David Rickey Trust.

F2: These securities are owned by the Dave Rickey and Daughters Foundation.

F3: These securities are owned by the Rickey Family Limited Partnership.

F4: The stock options vested 1/48th each month from date of grant.